Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Cytokine|September 1, 1992
The autocrine role of tumor necrosis factor in the proliferation and functional differentiation of human lymphokine-activated T killer cells (T-LAK) in vitroE K Innins, M Gatanaga, M Van Eden, et al.The Journal of Surgical Research|April 1, 1993
Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitroG Scannell, K Waxman, G J Kaml, et al.Lymphokine and Cytokine Research|October 1, 1993
The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitroY Abe, M Van Eden, M Gatanaga, et al.Endocrinology|April 1, 1992
Growth of the endometrial adenocarcinoma cell line AN3 CA is modulated by tumor necrosis factor and its receptor is up-regulated by estrogen in vitroE K Ininns, M Gatanaga, F Cappuccini, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1991
Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitroC A Dett, M Gatanaga, E K Ininns, et al.Journal of Biological Response Modifiers|December 1, 1988
Biological activities of novel recombinant tumor necrosis factor having N-terminal amino acid sequences derived from cytotoxic factors produced by THP-1 cellsG Soma, Y Tsuji, Y Tanabe, et al.Biochemical and Biophysical Research Communications|October 29, 1987
Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal regionG Soma, N Kitahara, Y Tsuji, et al.Gynecologic Oncology|July 1, 1993
Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancyE A Grosen, G A Granger, M Gatanaga, et al.Lymphokine and Cytokine Research|June 1, 1991
Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancerF Cappuccini, R S Yamamoto, P J DiSaia, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patientsT Gatanaga, C D Hwang, W Kohr, et al.Pageof 4